0.1884
Finanzdaten der Senti Biosciences Holdings Inc-Aktie (SNTI)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
6.25%
0.017
|
0.016 | - | - | - |
| Operating Expenses |
213.17%
14.51
|
4.632 | 18.66 | 16.95 | 16.80 |
| Operating Income/Loss |
213.89%
-14.49
|
-4.616 | -18.64 | -16.95 | -16.80 |
| Nonoperating Income/Loss |
340.25%
1.739
|
0.395 | 4.169 | -1.178 | 2.065 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
202.06%
-12.75
|
-4.221 | - | -18.13 | -14.73 |
| Net Income/Loss |
202.06%
-12.75
|
-4.221 | -14.47 | -18.13 | -14.73 |
| Basic Average Shares |
0.56%
31.14
|
30.97 | - | 26.23 | 26.08 |
| Diluted Average Shares |
0.56%
31.14
|
30.97 | - | 26.23 | 26.08 |
| Basic Earnings Per Share |
192.86%
-0.41
|
-0.14 | - | -0.69 | -0.56 |
| Diluted Earnings Per Share |
192.86%
-0.41
|
-0.14 | - | -0.69 | -0.56 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):